1. Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma
   Dannel Yeo et al, 2021, Cancers CrossRef
2. Engineered nanomaterials
   Enrico Bergamaschi et al, 2014, Biomarkers in Toxicology CrossRef
3. Newly established ELISA for N‐ERC/mesothelin improves diagnostic accuracy in patients with suspected pleural mesothelioma
   Tadashi Sato et al, 2014, Cancer Medicine CrossRef
4. Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis
   KRISTIAN MADEIRA et al, 2016, Anais da Academia Brasileira de Ciências CrossRef
5. Is Soluble Mesothelin-Related Protein an Upfront Predictive Marker of Pleural Mesothelioma? A Prospective Study on Italian Workers Exposed to Asbestos
   Rosa Filiberti et al, 2014, Oncology CrossRef
6. Serum Levels of N- and C-ERC/Mesothelin and Clinicopathological Factors in Mesothelioma Patients and Those without Mesothelioma
   AI KOYANAGI et al, 2023, Juntendo Medical Journal CrossRef
7. The utility of serum N-ERC/mesothelin as a biomarker of ovarian carcinoma
   HARUMI SAEKI et al, 2012, Oncology Letters CrossRef
8. Engineered Nanomaterials: Biomarkers of Exposure and Effect
   Enrico Bergamaschi et al, 2019, Biomarkers in Toxicology CrossRef
9. Retrospective analysis of large-scale research screening of construction workers for the early diagnosis of mesothelioma
   TOMOKO HIROHASHI et al, 2014, Molecular and Clinical Oncology CrossRef